Neuropathology of Progressive Supranuclear Palsy

Handbook of Clinical Neurology

Volumn 89, Issue , 2008, Pages 487-491

  Dickson, Dennis W ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROFILAMENT PROTEIN;

BRAIN; HUMAN; METABOLISM; NERVE CELL; NEUROFIBRILLARY TANGLE; PATHOLOGY; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; ULTRASTRUCTURE;

BRAIN; HUMANS; NEUROFIBRILLARY TANGLES; NEUROFILAMENT PROTEINS; NEURONS; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 66049120950     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)01245-6     Document Type: Review

References (28)

1. Arima K., Nakamura M., Sunohara N., et al. Ultrastructural characterization of the tau-immunoreactive tubules in the oligodendroglial perikarya and their inner loop processes in progressive supranuclear palsy. Acta Neuropathol (Berl) 93 (1997) 558-566
2. Baker M., Litvan I., Houlden H., et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 8 (1999) 711-715
3. Bigio E.H., Brown D.F., and White III C.L. Progressive supranuclear palsy with dementia: cortical pathology. J Neuropathol Exp Neurol 58 (1999) 359-364
4. Braak H., and Braak E. Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol 15 (1989) 13-26
5. Buee L., and Delacourte A. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol 9 (1999) 681-693
6. Conrad C., Andreadis A., Trojanowski J.Q., et al. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 41 (1997) 277-281
7. Dickson D.W., Kress Y., Crowe A., et al. Monoclonal antibodies to Alzheimer neurofibrillary tangles. 2. Demonstration of a common antigenic determinant between ANT and neurofibrillary degeneration in progressive supranuclear palsy. Am J Pathol 120 (1985) 292-303
8. Ishizawa K., Lin W.L., Tiseo P., et al. A qualitative and quantitative study of grumose degeneration in progressive supranuclear palsy. J Neuropathol Exp Neurol 59 (2000) 513-524
9. Josephs K.A., and Dickson D.W. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Mov Disord 18 (2003) 1018-1026
10. Josephs K.A., Boeve B.F., Duffy J.R., et al. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase 11 (2005) 283-296
11. Josephs K.A., Katsuse O., Beccano-Kelly D.A., et al. Atypical progressive supranuclear palsy with corticospinal tract degeneration. J Neuropathol Exp Neurol 65 (2006) 396-405
12. Kato T., Hirano A., Weinberg M.N., et al. Spinal cord lesions in progressive supranuclear palsy: some new observations. Acta Neuropathol (Berl) 71 (1986) 11-14
13. Kikuchi H., Doh-ura K., Kira J., et al. Preferential neurodegeneration in the cervical spinal cord of progressive supranuclear palsy. Acta Neuropathol (Berl) 97 (1999) 577-584
14. Komori T. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Brain Pathol 9 (1999) 663-679
15. Komori T., Arai N., Oda M., et al. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl) 96 (1998) 401-408
16. Liu W.K., Le T.V., Adamson J., et al. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. Ann Neurol 50 (2001) 494-502
17. Matsusaka H., Ikeda K., Akiyama H., et al. Astrocytic pathology in progressive supranuclear palsy: significance for neuropathological diagnosis. Acta Neuropathol (Berl) 96 (1998) 248-252
18. Nishimura M., Namba Y., Ikeda K., et al. Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy. Neurosci Lett 143 (1992) 35-38
19. Rademakers R., Melquist S., Cruts M., et al. High- density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum Mol Genet 14 (2005) 3281-3292
20. Rojo A., Pernaute R.S., Fontan A., et al. Clinical genetics of familial progressive supranuclear palsy. Brain 122 (1999) 1233-1245
21. Steele J.C., Richardson J.C., and Olszewski J. Progressive supranuclear palsy. a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10 (1964) 333-359
22. Tagliavini F., Pilleri G., Bouras C., et al. The basal nucleus of Meynert in patients with progressive supranuclear palsy. Neurosci Lett 44 (1984) 37-42
23. Tellez-Nagel I., and Wisniewski H.M. Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Arch Neurol 29 (1973) 324-327
24. Togo T., Cookson N., and Dickson D.W. Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E. Brain Pathol 12 (2002) 45-52
25. Tsuboi Y., Slowinski J., Josephs K.A., et al. Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 60 (2003) 1766-1769
26. Tsuboi Y., Josephs K.A., Boeve B.F., et al. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord 20 (2005) 982-988
27. Warren N.M., Piggott M.A., Perry E.K., et al. Cholinergic systems in progressive supranuclear palsy. Brain 128 (2005) 239-249
28. Williams D.R., de Silva R., Paviour D.C., et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 128 (2005) 1247-1258